Acute lymphoblastic leukemia type b is supposed to refer to acute B-lymphoblastic leukemia, and its cure rate varies from person to person, ranging from 10% to 85%, with a very high cure rate in children and a poorer rate in the elderly.
Acute B-lymphoblastic leukemia is a subtype of leukemia with high to low cure rates between 10% and 85%, stratified by prognostic risk such as patient age.
Acute B-lymphoblastic leukemia in children can be treated with intensive chemotherapy with cure rates ranging from 70% to 85%. In adults, the cure rate for acute B-lymphoblastic leukemia drops dramatically to 30% to 50%. in elderly patients over 60 years of age, the cure rate may be less than 15%.
There are many treatment options for acute B-lymphoblastic leukemia, such as targeted therapy (cidaphenamide), chemotherapy (vincristine), hematopoietic stem cell transplantation, and CART therapy. If the combination of Philadelphia chromosome positivity, it can be combined with TKI-targeted therapy (imatinib), which may improve the cure rate.
Specific disease diagnosis and treatment should be under the supervision of a physician.